---

Comparison of intravenous granisetron and intravenous lignocaine to alleviate pain on propofol injection: A double blind, randomized, controlled trial

Full Text PDF

---

Original Article

Author Details : Priyanka Suresh*, Shivakumar K Patil

Volume : 7, Issue : 2, Year : 2020

Article Page : 319-323

https://doi.org/10.18231/j.ijca.2020.057

Suggest article by email

Get Permission

Abstract

Background: The objective of the study was to compare effectiveness of intravenous (IV) granisetron (2
milligram) with IV lignocaine (30 milligram) in allaying pain on propofol IV administration measured at
15 seconds after propofol administration.
Materials and Methods: 100 patients of age 18-50 years belonging to American Society of
Anesthesiologists (ASA) physical status grades I and II, chosen for elective surgery were randomized to two
different groups (group L and group G) of 50 each. Patients of group L received IV lignocaine 30 mg and
the other group G received IV granisetron 2 mg as pretreatment, before administration of propofol. Patients
were assessed for pain after 15 seconds of IV administration of propofol with McCririck and Hunter scale.
Results: Both the pretreatments were found to prevent or decrease the pain on propofol administration.
Pain assessed at the end of 15 seconds of propofol administration, showed that 76% in lignocaine group &
62%in granisetron group were not having any pain, 12% in lignocaine group and 20% in granisetron group
had mild pain, and 12% in lignocaine group and 18% in granisetron group had moderate pain as assessed
with McCririck and Hunter scale. There was no significant difference in the pain scores between the groups
(c2 = 2.310, P= 0.315).
Conclusion: Both IV granisetron (2 mg) and IV lignocaine (30 mg) are equally effective in allaying pain
on propofol injection.

Keywords: Granisetron, lignocaine, Pretreatment, Propofol-induced pain.

How to cite : Suresh P, Patil S K, Comparison of intravenous granisetron and intravenous lignocaine to alleviate pain on propofol injection: A double blind, randomized, controlled trial. Indian J Clin Anaesth 2020;7(2):319-323

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.